[1]耿峻,吴兴勇,胡德胜,等.前列腺癌48例患者全身核素骨显像的临床价值[J].国际放射医学核医学杂志,2007,31(4):238-238.
点击复制

前列腺癌48例患者全身核素骨显像的临床价值(/HTML)
分享到:

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
31
期数:
2007年第4期
页码:
238-238
栏目:
临床核医学
出版日期:
1900-01-01

文章信息/Info

作者:
耿峻 吴兴勇 胡德胜 何健 范贤东
641000 四川, 四川省内江市第一人民医院核医学科
关键词:
前列腺肿瘤骨肿瘤肿瘤转移99m锝亚甲基二膦酸盐放射性核素显像
分类号:
R817.4
摘要:
前列腺癌是老年男性最常见的肿瘤,好发年龄在50岁以上,而且通过血运转移至骨骼的发生率较高,患者出现临床症状来医院就诊时多已发生骨转移。

参考文献/References:

1 焦松,黄翼然,邱丰,等. 前列腺癌骨转移的核素骨显像.上海第二医科大学学报,1998,18(3):202-203.
2 Wymenga L,Boomsma J,Groenier K,et al. Routine bone scans in patients with prostate cancer related to serum prostatespecific antigen and alkaline phosphatase.BJU Int,2001,88(3):226-230.
3 Shreve,Orossman H,Oross M,et al. Metastatie prostate cancer:Initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose.Radiology,1996,199(3):754-756.

相似文献/References:

[1]王朋,崔邦平,代文莉,等.18F-FDG PET/CT在前列腺癌中的应用进展[J].国际放射医学核医学杂志,2016,40(4):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
 Wang Peng,Cui Bangping,Dai Wenli,et al.Progress in the application of 18F-FDG PET/CT in prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
[2]廖光星,冷志欣,肖国有.前列腺癌骨转移影像诊断方法研究进展[J].国际放射医学核医学杂志,2016,40(6):464.[doi:10.3760/cma.j.issn.1673-4114.2016.06.012]
 Liao Guangxing,Leng Zhixin,Xiao Guoyou.Progress of imaging in the diagnosis of bone metastases of prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):464.[doi:10.3760/cma.j.issn.1673-4114.2016.06.012]
[3]周文兰,吴湖炳,韩彦江,等.18F-FDG PET/CT对骨骼孤立性高代谢病灶的初步诊断价值[J].国际放射医学核医学杂志,2015,39(1):14.[doi:10.3760/cma.j.issn.1673-4114.2015.01.005]
 Zhou Wenlan,Wu Hubing,Han Yanjiang,et al.Preliminary study of 18F-FDG PET/CT in the diagnosis of solitary hypermetabolic lesion of bone[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):14.[doi:10.3760/cma.j.issn.1673-4114.2015.01.005]
[4]刘辰,杨悦,张雪宁,等.MRI和1997年版Partin表对前列腺癌病理特征预测准确性的对比研究[J].国际放射医学核医学杂志,2015,39(2):124.[doi:10.3760/cma.j.issn.1673-4114.2015.02.005]
 Liu Chen,Yang Yue,Zhang Xuening,et al.Accuracy of MRI and 1997 edition of Partin tables in predicting the pathological features of prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):124.[doi:10.3760/cma.j.issn.1673-4114.2015.02.005]
[5]桂继琮,刘兴党.镭-223氯化物治疗去势抵抗性前列腺癌骨转移的研究进展[J].国际放射医学核医学杂志,2015,39(3):268.[doi:10.3760/cma.j.issn.1673-4114.2015.03.018]
 Gui Jicong,Liu Xingdang.Development in the study of radium-223 chloride for treating castration-resistant prostate carcinoma with bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):268.[doi:10.3760/cma.j.issn.1673-4114.2015.03.018]
[6]张晖,段清,卓娜,等.经直肠超声引导下“6+X”点法前列腺穿刺活检诊断前列腺癌的临床价值分析[J].国际放射医学核医学杂志,2015,39(4):308.[doi:10.3760/cma.j.issn.1673-4114.2015.04.008]
 Zhang Hui,Duan Qing,Zhuo Na,et al.Meta-analysis of the diagnostic value of transrectal ultrasound-guided “6+X” points biopsy in prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):308.[doi:10.3760/cma.j.issn.1673-4114.2015.04.008]
[7]张龙敏,刘爱连.前列腺癌MRI诊断技术研究进展[J].国际放射医学核医学杂志,2014,38(1):53.[doi:10.3760/cma.j.issn 1673-4114.2014.01.011]
 Zhang Longmin,Liu Ailian.Advances in MRI diagnosis of prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(4):53.[doi:10.3760/cma.j.issn 1673-4114.2014.01.011]
[8]刘辰,杨悦,张雪宁,等.CT/MRI图像融合在前列腺癌IMRT中的应用进展[J].国际放射医学核医学杂志,2014,38(4):247.[doi:10.3760/cma.j.issn.1673-4114.2014.04.010]
 Liu Chen,Yang Yue,Zhang Xuening,et al.CT/MRI image fusion in intensity modulated radiation therapy for prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(4):247.[doi:10.3760/cma.j.issn.1673-4114.2014.04.010]
[9]刘超,邓智勇,刘鹏杰,等.89SrCL2与唑来膦酸联合治疗乳腺癌转移性骨肿瘤的疗效分析[J].国际放射医学核医学杂志,2014,38(5):300.[doi:10.3760/cma.j.issn.1673-4114.2014.05.006]
 Liu Chao,Deng Zhi-yong,Liu Peng-jie,et al.Analysis on the curative effect of combination therapy with zoledronic acid and 89SrCL2 on bone tumor with breast cancer metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(4):300.[doi:10.3760/cma.j.issn.1673-4114.2014.05.006]
[10]韦赐秋.中老年男性血清前列腺特异性抗原测定的临床价值[J].国际放射医学核医学杂志,2010,34(5):302.[doi:10.3760/cma.j.issn.1673-4114.2010.05.014]
[11]袁超,李卫鹏,胡永全,等.89Sr治疗乳腺癌和前列腺癌多发性骨转移的临床观察[J].国际放射医学核医学杂志,2010,34(4):220.[doi:10.3760/cma.j.issn.1673-4114.2010.04.008]
 YUAN Chao,LI Wei-peng,HU Yong-quan,et al.Clinical observation of 89Sr treatment efficacy of multiple bone metastases in breast and prostate cancer patients[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(4):220.[doi:10.3760/cma.j.issn.1673-4114.2010.04.008]

备注/Memo

备注/Memo:
收稿日期:2007-01-04。
基金项目:全军"十一五"医药卫生专项基金项目(06Z064)
通讯作者:耿竣(E-mail:njadl@163.com)
更新日期/Last Update: 1900-01-01